Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,699,936
-$36,214,356 QoQ
Shares Held
922,479
-50.6% QoQ
Ownership
0.532%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#46
of 321 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. COGT ranks #33 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in COGT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,699,936 | 922,479 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $71,914,292 | 1,868,389 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $79,841,998 | 2,247,804 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $21,984,082 | 1,530,925 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,963,981 | 273,535 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,303,010 | 217,531 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,651,905 | 339,988 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,938,062 | 457,228 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,518,132 | 298,711 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,032,278 | 451,232 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $345,749 | 58,801 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,077,628 | 110,526 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,393,527 | 202,156 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,983,188 | 461,834 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,478,797 | 733,460 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,429,089 | 900,073 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,767,027 | 195,901 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $221,475 | 25,813 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||